Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

A Study of Intensity-Modulated Pleural Radiation Therapy (IMPRINT) in People With Thymic Cancer That Has Spread to the Lining of the Lungs and Chest

Phase 2

Recruiting

Conditions: Pleural Metastases
Thymic Malignancies

Interventions: Radiation: Intensity-Modulated Pleural Radiation Therapy (IMPRINT)

First Posted Date: 2022-04-29

Last Posted Date: 2024-07-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 36

Registration Number: NCT05354570

Locations: 🇺🇸
Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Suffolk - Commack (Limited protocol activities), Commack, New York, United States

and more 4 locations

A Study of the Use of Acellular Dermal Matrix for Breast Reconstruction

Phase 3

Active, not recruiting

Conditions: Breast Cancer

Interventions: Procedure: Prepectoral Breast Reconstruction without Acellular Dermal Matrix (ADM)
Procedure: Prepectoral Breast Reconstruction with Acellular Dermal Matrix (ADM)

First Posted Date: 2022-04-07

Last Posted Date: 2025-02-13

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 353

Registration Number: NCT05316324

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
🇺🇸
Memorial Sloan Kettering Nassau (Limited Protocol Activities), Rockville Centre, New York, United States

A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)

Phase 2

Recruiting

Conditions: Oropharynx Cancer
HPV
HPV-Related Carcinoma
HPV Positive Oropharyngeal Squamous Cell Carcinoma
HPV-Related Malignancy

Interventions: Diagnostic Test: HPV ctDNA Assay
Diagnostic Test: MRI Studies
Behavioral: EORTC QLQ H&N 35 and C30
Behavioral: MDADI-HN
Behavioral: COST-FACIT
Combination Product: Chemoradiation (Arm B)
Radiation: Intensity-Modulated Radiation Therapy (Arm A)

First Posted Date: 2022-04-01

Last Posted Date: 2025-05-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 30

Registration Number: NCT05307939

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited protocol activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides

Phase 1

Recruiting

Conditions: Cutaneous T-cell Lymphoma

Interventions: Drug: Bexarotene
Radiation: Total Skin Electron Beam (TSEB)

First Posted Date: 2022-03-25

Last Posted Date: 2025-04-08

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 20

Registration Number: NCT05296304

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

A Study on Radiation Therapy Guided by the Reflectance Confocal Microscopy (RCM)/Optical Coherence Tomography (OCT) Device in People With Basal Cell Carcinoma

Phase 2

Active, not recruiting

Conditions: Basal Cell Carcinoma

Interventions: Device: Reflectance ConfocaL Microscopy And Optical Coherence Tomography Guided
Radiation: Radiation Therapy

First Posted Date: 2022-03-24

Last Posted Date: 2025-04-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 38

Registration Number: NCT05294120

Locations: 🇺🇸
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

and more 4 locations

A Study of How Proton Beam Radiotherapy (PBRT) Affects Brain Function and Quality of Life in Children and Young Adults Undergoing Treatment for a Brain Tumor

Not Applicable

Recruiting

Conditions: Metastatic Brain Tumor
Brain Tumor

Interventions: Diagnostic Test: Resting-state functional connectivity MRI
Other: Neurocognitive battery with quality-of-life assessment

First Posted Date: 2022-03-21

Last Posted Date: 2025-05-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 40

Registration Number: NCT05288439

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

CD8+ T Cell Imaging During Pre-surgery Immunotherapy in People With Melanoma

Phase 2

Recruiting

Conditions: Melanoma
Melanoma Stage III

Interventions: Diagnostic Test: PET Scan
Drug: Nivolumab
Drug: Ipilimumab
Procedure: Surgical Resection of Melanoma

First Posted Date: 2022-03-21

Last Posted Date: 2025-04-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 28

Registration Number: NCT05289193

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States

and more 1 locations

A Study of LY2880070 and Gemcitabine in People With Ewing Sarcoma,Ewing-Like Sarcoma, and Desmoplastic Small Round Cell Tumor

Phase 2

Recruiting

Conditions: Ewing Sarcoma
Ewing-Like Sarcoma

Interventions: Drug: LY2880070
Drug: Gemcitabine

First Posted Date: 2022-03-11

Last Posted Date: 2025-05-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 24

Registration Number: NCT05275426

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

Survey on Lymphedema After Sentinel Lymph Node Biopsy in People With Cervical or Vulvar Cancer

Recruiting

Conditions: Cervical Cancer
Vulvar Cancer

Interventions: Other: Questionnaires

First Posted Date: 2022-02-24

Last Posted Date: 2025-01-07

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 1026

Registration Number: NCT05255393

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Enfortumab Vedotin and Pembrolizumab in People with Bladder Cancer

Phase 2

Recruiting

Conditions: Urothelial Carcinoma

Interventions: Drug: Enfortumab vedotin
Drug: Pembrolizumab

First Posted Date: 2022-02-15

Last Posted Date: 2025-02-26

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 23

Registration Number: NCT05239624

Locations: 🇺🇸
Baptist Alliance MCI, Miami, Florida, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

and more 7 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy